• 1. The Second Medical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, P.R.China;
  • 2. Department of Rehabilitation, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, P.R.China;
  • 3. Department of EBM & Clinical Research Service Group, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, P.R.China;
  • 4. Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou 510120, P.R.China;
GUO Xinfeng, Email: guoxinfeng@gzucm.edu.cn
Export PDF Favorites Scan Get Citation

Objective To systematically review the outcomes reported in clinical trials of post-stroke dysarthria.Methods PubMed, The Cochrane Library, EMbase, CNKI, Sinomed, WanFang Data and VIP databases were electronically searched to collect randomized controlled trials (RCTs) of post-stroke dysarthria from inception to December 6th, 2019. Two reviewers independently screened literature, extracted data and analyzed outcomes using qualitative method.Result A total of 112 RCTs involving 39 outcomes (therapeutic effect assessment outcomes and safety outcomes) were included. The top 4 outcomes were the Frenchay dysarthria assessment scale, the dysarthria examination method developed by the Chinese rehabilitation center, the evaluation of the speech therapists or clinicians and GRBAS.Conclusions Current evidence shows that there is no acceptable outcomes for post-stroke dysarthria. It is recommended to improve the suitable assessment scale for Chinese to improve quality of studies on post-strohe dysarthria.

Citation: XIE Qianwen, XIAO Jingmin, LIU Shaonan, YANG Lihong, CHEN Yi, LIU Yingfen, YANG Haifang, GUO Xinfeng. Outcomes reported in clinical trials of post-stroke dysarthria: a systematic review. Chinese Journal of Evidence-Based Medicine, 2020, 20(6): 708-712. doi: 10.7507/1672-2531.202001053 Copy

  • Previous Article

    The relationship between cadmium and childhood autism: a meta-analysis
  • Next Article

    Robustness assessment of meta-analysis results based on enhanced funnel plots and trial sequential analysis